Cuimin Ding

1.5k total citations
30 papers, 313 citations indexed

About

Cuimin Ding is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Cuimin Ding has authored 30 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Cuimin Ding's work include Lung Cancer Treatments and Mutations (11 papers), MicroRNA in disease regulation (9 papers) and Lung Cancer Research Studies (8 papers). Cuimin Ding is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), MicroRNA in disease regulation (9 papers) and Lung Cancer Research Studies (8 papers). Cuimin Ding collaborates with scholars based in China and United States. Cuimin Ding's co-authors include Zhanjun Guo, Ruijuan Li, Shengmian Li, Bin Li, Bin Li, Hui Ge, Ping Wang, Hao Jin, Mengmeng Gao and Wei Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Cuimin Ding

29 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cuimin Ding China 11 214 151 77 66 23 30 313
Miljana Nenkov Germany 10 171 0.8× 125 0.8× 53 0.7× 64 1.0× 20 0.9× 12 267
Chunyuan Xue China 7 181 0.8× 143 0.9× 49 0.6× 51 0.8× 25 1.1× 9 248
Huanlei Wu China 10 201 0.9× 124 0.8× 86 1.1× 80 1.2× 18 0.8× 15 319
Mingdian Lu China 9 198 0.9× 101 0.7× 50 0.6× 45 0.7× 19 0.8× 15 271
Xiaonan Sheng China 10 201 0.9× 193 1.3× 137 1.8× 51 0.8× 24 1.0× 22 332
Ana Lameirinhas Portugal 12 269 1.3× 188 1.2× 54 0.7× 72 1.1× 19 0.8× 18 386
Xuetao Shi China 9 174 0.8× 147 1.0× 32 0.4× 45 0.7× 22 1.0× 13 292
Beige Zong China 10 167 0.8× 119 0.8× 66 0.9× 125 1.9× 14 0.6× 15 321
Fan Chao China 10 225 1.1× 152 1.0× 72 0.9× 39 0.6× 14 0.6× 21 309

Countries citing papers authored by Cuimin Ding

Since Specialization
Citations

This map shows the geographic impact of Cuimin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuimin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuimin Ding more than expected).

Fields of papers citing papers by Cuimin Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuimin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuimin Ding. The network helps show where Cuimin Ding may publish in the future.

Co-authorship network of co-authors of Cuimin Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Cuimin Ding. A scholar is included among the top collaborators of Cuimin Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuimin Ding. Cuimin Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Peng, Jingcui, Bin Li, Feng He, & Cuimin Ding. (2022). Lung infection caused by Blastoschizomyces capitatus without immunodeficiency: a case report and review of the literature. Annals of Palliative Medicine. 11(12). 3826–3832. 3 indexed citations
5.
He, Xin, et al.. (2022). A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer. Journal of Thoracic Disease. 14(6). 2103–2111. 2 indexed citations
6.
Li, Bin, et al.. (2021). Association Between PDL1 Genetic Variation and Efficacy of Apatinib Monotherapy in Patients with Previously Treated Advanced NSCLC: A Real-World Retrospective Study. International Journal of General Medicine. Volume 14. 2703–2714. 7 indexed citations
7.
8.
Wang, Yun, et al.. (2021). The role of autoantibody detection in the diagnosis and staging of lung cancer. Annals of Translational Medicine. 9(22). 1673–1673. 7 indexed citations
9.
10.
Liu, Yutao, Xuezhi Hao, Deruo Liu, et al.. (2020). <p>Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial</p>. Cancer Management and Research. Volume 12. 4633–4643. 9 indexed citations
11.
Deng, Huiyan, et al.. (2019). Clinical observation of crizotinib in the treatment of ALK-positive advanced non-small cell lung cancer. Pathology - Research and Practice. 215(12). 152695–152695. 5 indexed citations
12.
Xu, Yan, Li Zhang, Jian Fang, et al.. (2018). Establishment of a prospective multicenter cohort for advanced non‐small cell lung cancer in China (CAPTRA‐Lung study). Thoracic Cancer. 9(12). 1795–1800. 4 indexed citations
13.
14.
Zhang, Zhaoqi, et al.. (2016). 99m Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma. Cancer Biotherapy and Radiopharmaceuticals. 31(7). 238–245. 8 indexed citations
15.
Ding, Cuimin, et al.. (2016). miR-19a/b modulates lung cancer cells metastasis through suppression of MXD1 expression. Oncology Letters. 12(3). 1901–1905. 18 indexed citations
16.
Guo, Zhanjun, et al.. (2013). A microRNA-related single nucleotide polymorphism of the XPO5 gene is associated with survival of small cell lung cancer patients. Biomedical Reports. 1(4). 545–548. 21 indexed citations
17.
Ding, Cuimin, et al.. (2012). Sequence polymorphisms of the mitochondrial displacement loop and outcome of non-small cell lung cancer. Experimental and Therapeutic Medicine. 3(5). 861–864. 11 indexed citations
18.
Ding, Cuimin, et al.. (2012). Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for lung cancer. Mitochondrial DNA. 23(4). 251–254. 37 indexed citations
19.
Ding, Cuimin, et al.. (2012). A polymorphism at the miR-502 binding site in the 3′ untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer. Experimental and Therapeutic Medicine. 3(4). 689–692. 34 indexed citations
20.
Ji, Hui & Cuimin Ding. (2008). Secondary resistance of gefitinib in non-small-cell lung cancer treatment. 35(12). 908–910. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miljana Nenkov Breakdown of academic impact, for papers by Chunyuan Xue Breakdown of academic impact, for papers by Huanlei Wu Breakdown of academic impact, for papers by Mingdian Lu Breakdown of academic impact, for papers by Xiaonan Sheng Breakdown of academic impact, for papers by Ana Lameirinhas Breakdown of academic impact, for papers by Xuetao Shi Breakdown of academic impact, for papers by Beige Zong Breakdown of academic impact, for papers by Fan Chao
Rankless by CCL
2026